Lawmakers Review FDA’s Investigation Of J&J Stent
U.S. Rep. John Dingell (D-Mich.), chair of the House Committee on Energy and Commerce, and U.S. Rep. Bart Stupak (D-Mich.), chair of the Subcommittee on Oversight and Investigations, requested the records from J&J in a letter on Monday as they review how effective the FDA is in its...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login